Ledger.Open graph →
SEC Form D · filed December 22, 2021

Good Therapeutics, Inc

Offering
$26.4M
Sold
$8.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Karl Handelsman · Seattle, WADirectorJohn Mulligan · Seattle, WAExec · Director · PromoterJohn Mckearn · San Carlos, CADirectorDiane Hollenbaugh · Seattle, WAExecMonique Schiersing · Seattle, WADirectorNeela Patel · Seattle, WAExecNicholas Walrod · Portland, ORDirectorKarl Handelsman · Seattle, WADirectorJohn Mulligan · Seattle, WAExec · Director · PromoterNicholas Walrod · TEMPE, AZDirectorJohn Mckearn · San Mateo, CADirectorDiane Hollenbaugh · Seattle, WAExecMonique Schiersing · Seattle, WADirectorNeela Patel · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗